Featured

3 May 2022

The MM+M Agency 100 report: Oxford PharmaGenesis recognized as industry leader for the second year running

For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.

All
Show
  • All
  • News
  • Articles
  • Events

Supporting research at the University of Oxford: Oxford PharmaGenesis funds studentship at Green Templeton College to explore the impact of race and ethnicity on emerging digital techniques in dermatology

Oxford PharmaGenesis is delighted to support a funded DPhil studentship in Translational Health Sciences in collaboration with Green Templeton College at the University of Oxford, UK. The studentship will examine the importance of diversity in dermatology, particularly when applying emerging techniques in artificial intelligence and machine learning. Applications are now open. Please help to spread […]

The MM+M Agency 100 report: Oxford PharmaGenesis recognized as industry leader for the second year running

For the second year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.

Promoting diversity in clinical trials: Oxford PharmaGenesis sponsors latest CISCRP campaign

Oxford PharmaGenesis is proud to sponsor the latest CISCRP clinical trials education campaign to raise awareness and understanding of clinical research among minority urban communities in cities across the USA and among the wider general public.

Public health initiative MS Brain Health shortlisted for Communiqué 'Excellence' Award

Oxford PharmaGenesis has been shortlisted for the Communiqué Awards 2022 for the Award for Excellence in Public Health Communications for MS Brain Health, on behalf of Oxford Health Policy Forum. This global policy initiative has changed the way that leading multiple sclerosis (MS) experts view best practice in MS care.

Our industry partnership accelerates citation screening in systematic literature reviews by 25% with the help of artificial intelligence

Citation (title and abstract) screening for a systematic literature review may be accelerated by 25% through the application of artificial intelligence (AI) in a novel method developed by Oxford PharmaGenesis in partnership with Vyasa. The evidence reported in systematic literature reviews derives from articles that have passed a rigorous screening process. According to a recent study, our new, […]

Exploring new frontiers in HealthScience communications at the 18th Annual Meeting of ISMPP

Creativity, diversity, data visualization and plain language summaries all took centre stage at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 9–11 May 2022 in Washington, DC, USA.